Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I
DEA temporarily places 2-fluorodeschloroketamine (2-FDCK) into Schedule I, making it illegal to possess, sell, or distribute. This does not directly affect cannabis or hemp operators unless they handle this specific substance.
Aforeworn detected this change in the Cannabis & Hemp Operators space on July 5, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Cannabis and hemp operators (cultivators, dispensaries, processors, hemp-derived THC brands) who do not handle 2-FDCK are not affected. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediate upon publication (May 22, 2026).. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Cannabis & Hemp Operators continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
2-FDCK is now a Schedule I controlled substance under the CSA.
Who it affects
Cannabis and hemp operators (cultivators, dispensaries, processors, hemp-derived THC brands) who do not handle 2-FDCK are not affected.
What you must do
No action needed for operators not dealing with 2-FDCK. If you handle it, cease all activities and secure inventory.
Deadline
Immediate upon publication (May 22, 2026).
Never miss a change like this again
Aforeworn watches Cannabis & Hemp Operators around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Cannabis & Hemp Operators
- Oregon Liquor and Cannabis Commission : Marijuana and Hemp (Cannabis) : Marijuana and Hemp (Cannabis) : State of Oregon
- Rulemaking - Department of Cannabis Control
- Federal Acquisition Regulation: List of Domestically Nonavailable Articles
- Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Food and Drug Administration's Adverse Event and Product Experience Reporting Program
- Exempt Chemical Preparations Under the Controlled Substances Act